Obestatin and growth hormone reveal the interaction of central obesity and other cardiometabolic risk factors of metabolic syndrome

Obestatin and growth hormone reveal the interaction of central obesity and other cardiometabolic risk factors of metabolic syndrome

Abstract Metabolic syndrome (MetS) is a multi-factorial disorder including central obesity (CO), insulin resistance, hyperglycemia, dyslipidemia and hypertension which increases the risk of diabetes mellitus and cardiovascular diseases. CO is considered as an essential component of MetS according to...

Full description

Bibliographic Details
Main Authors: Angus P. Yu, Felix N. Ugwu, Bjorn T. Tam, Paul H. Lee, Vicki Ma, Simon Pang, Angel S. Chow, Kenneth K. Cheng, Christopher W. Lai, Cesar S. Wong, Parco M. Siu
Format: Article
Language:English
Published: Nature Publishing Group 2020-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-62271-w

Internet

https://doi.org/10.1038/s41598-020-62271-w

Similar Items